About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
How to Use Firebase to Send Push Notifications to React Native and Node.js Apps
Firebase Cloud Messaging (FCM) is a cross-platform messaging solution that allows app developers to send notifications to devices on Android, iOS, and the web. FCM supports sending messages to…
|
How to Use DDEV to Streamline Your Drupal Development Process
DDEV is an innovative open-source tool designed to streamline Drupal development. By utilizing Docker containers, it offers consistent and efficient local development environments across various…
|
How to Use AWS to Automate Your IT Operations
Use AWS services to automate your IT operations and save time and money. AWS offers a wide range of services that can help you automate tasks such as provisioning and managing servers, deploying…
|
Migrating to the Cloud: A Comprehensive Guide for Businesses
Discover the benefits of cloud migration. Migrate seamlessly to the cloud with Valuebound, your trusted AWS partner. Unlock your business's full potential.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
